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Abstract 11 
Some apicomplexan parasites have evolved distinct protein kinase families to modulate 12 
host cell structure and function. Toxoplasma gondii rhoptry protein kinases and pseudokinases 13 
(ROPKs) are involved in virulence and modulation of host cell signaling. The proteome of 14 
Plasmodium falciparum contains a family of putative kinases called FIKKs, some of which are 15 
exported to the host red blood cell and might play a role in erythrocyte remodeling. In this 16 
review we will discuss kinases known to be critical for host cell invasion, intracellular growth 17 
and egress, focusing on (i) calcium-dependent protein kinases (CDPKs) and (ii) the secreted 18 
kinases that are unique to Toxoplasma (ROPKs) and Plasmodium (FIKKs). 19 
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 25 
Introduction 26 
Protein kinases mediate the transfer of phosphate groups from ATP to specific residues on their 27 
target proteins, resulting in changes in the activity, stability, interactions with ligands or 28 
localization of the phosphorylated substrates.  Kinases themselves are often similarly regulated, 29 
and many of them function as signaling mediators that integrate upstream signals in the form of 30 
second messengers, post translational modifications or binding of regulatory proteins.  It is 31 
therefore not surprising that many parasites have evolved distinct protein kinase families with 32 
novel domain structures and biochemical features to regulate key parasite-specific physiological 33 
processes that must be executed in a timely fashion during development or in response to 34 
external stimuli and physiological cues from the host.  As signaling mediators, protein kinases 35 
are also well suited to function at the host-parasite interface, where they can perturb host 36 
signaling pathways, activate dormant mechanisms in the host cell, or disrupt the proper 37 
functioning of host proteins. 38 
Both Toxoplasma and Plasmodium contain a family of calcium-dependent protein kinases 39 
(CDPKs), whose occurrence is restricted to plants and Alveolates (the superphylum that 40 
comprises Ciliates and Apicomplexa), although trypanosomatids also possess kinases with an 41 
EF-hand calcium binding domain that are thought to be phylogenetically distinct form plant and 42 
Alveolate CDPKs.  CDPKs have a domain structure consisting of a calcium-binding domain 43 
fused to the kinase domain, such that kinase activity is stimulated upon calcium binding.  Studies 44 
of apicomplexan CDPKs have revealed a conserved regulatory mechanism and highlighted the 45 
importance of calcium in regulating a number of key physiological processes including host cell 46 
attachment and invasion, gliding motility, and parasite egress. 47 
Toxoplasma gondii, a highly prevalent obligate intracellular protozoan parasite, seems to 48 
rely for a large part on protein kinases and pseudo kinases to modify the host cell. Toxoplasma is 49 
capable of infecting all nucleated cells of most warm-blooded animals. This ability to establish a 50 
chronic infection in such a wide range of host species and cell types is likely associated with its 51 
ability to modify many aspects of the host cell’s normal physiology. It does this by secreting 52 
proteins from the rhoptry, a specialized secretory organelle that is found only in apicomplexan 53 
parasites, directly into the host cytosol where they can exert their function. Many rhoptry 54 
proteins have homology to kinases and a large proportion of them are predicted to be 55 
pseudokinases.  56 
Malaria parasites (genus Plasmodium) also belong to the Apicomplexa, however, unlike 57 
Toxoplasma, they have a very restricted range of host cells which they can invade and in which 58 
they can replicate.  After inoculation into the vertebrate host through the bite of an infected 59 
mosquito, Plasmodium sporozoites must first invade hepatocytes, where they undergo asexual 60 
proliferation (exo-erythrocytic schizogony), generating several thousand merozoites in the 61 
process. This strict dependence on hepatocytes for the pre-erythrocytic stage of infection has, 62 
however, recently been challenged by in vivo observations of P. berghei parasites developing in 63 
dermal and epidermal cells at the site of inoculation and generating infective merozoites 64 
(Gueirard et al., 2010). 65 
 The only cell type permissive for invasion by Plasmodium merozoites is the red blood 66 
cell (RBC).  Invasion involves release of the contents of rhoptries and micronemes (another type 67 
of specialized secretory organelle) and formation of a parasitophorous vacuole.  The parasite 68 
causes considerable modifications to its host RBC that include the establishment of a complex 69 
trafficking system that mediates translocation of parasite-encoded proteins to the RBC 70 
membrane skeleton and surface (Cooke et al., 2004). 71 
In the case of P. falciparum, the most lethal of the five species of malaria parasites that can infect 72 
humans, such proteins include components of the so-called “knob” structures, through which 73 
parasite-infected RBCs adhere to vascular endothelial cells, thereby significantly contributing to 74 
pathogenesis (Cooke et al., 2001; Cooke, B.M., N. Mohandas, and R.L. Coppel, Malaria and the 75 
red blood cell membrane. Semin Hematol, 2004. 41(2): p. 173-88; Maier, A.G., et al., Malaria 76 
parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol, 2009. 7(5): p. 341-54.). 77 
 78 
There are no orthologues of the Toxoplasma rhoptry kinases in malaria parasites,  however, the 79 
P. falciparum kinome includes a family (20 members) of related kinase-like sequences called 80 
FIKKs, due to the presence of a Phe-Ile-Lys-Lys motif they share in their kinase domain (Ward 81 
et al., 2004). Most notably, 18 of the 20 fikk genes in P. falciparum are predicted to encode fully 82 
functional kinases, 16 of which are predicted to be exported into the host RBC (Schneider and 83 
Mercereau-Puijalon, 2005), and at least some of these enzymes have been shown to be exported 84 
to the host RBC and to be associated with kinase activity (Nunes et al., 2007; Nunes et al., 2010). 85 
Many of the Toxoplasma and Plasmodium kinases are related to kinases with known functions in 86 
other eukaryotes and these will not be discussed in this review. Instead, we will discuss in more 87 
detail, kinases from these parasites that are known to be critical for host cell invasion, 88 
intracellular growth and parasite egress, focusing on (i) calcium-dependent protein kinases 89 
(CDPKs) and (ii)  the secreted kinases that are unique to Toxoplasma (ROPKs) and Plasmodium 90 
(FIKKs). 91 
 92 
Calcium-dependent regulation of invasion and egress: 93 
 Calcium levels in T. gondii play key roles in regulating micronemal secretion-dependent 94 
processes including host cell invasion, gliding motility and parasite egress {Nagamune, 2008 95 
#13506}.  Chelation of parasite intracellular calcium strongly inhibited both microneme release 96 
and invasion of host cells, and this effect was partially reversed by raising intracellular calcium 97 
using the ionophore A23187 (Carruthers et al., 1999). Additionally, evidence was also provided 98 
in this study for the requirement of a staurosporine-sensitive kinase activity in regulating 99 
microneme discharge and for parasite invasion of host cells. 100 
In Toxoplasma parasites, calcium-dependent protein kinases (CDPKs) were shown to be 101 
involved in host cell invasion through the use of KT5926, an inhibitor of CDPKs in other 102 
systems (Kieschnick et al., 2001). KT5926 blocks the motility of Toxoplasma tachyzoites and 103 
their attachment to host cells. In vivo, the phosphorylation of only three parasite proteins was 104 
found to be blocked by KT5926 (although there may be more), and in parasite extracts, a single 105 
KT5926-sensitive protein kinase activity was detected. This activity was calcium-dependent but 106 
did not require calmodulin. In a search for CDPKs in Toxoplasma, two members of the class of 107 
calmodulin-like domain protein kinases (CDPKs) were detected. TgCDPK2 was only expressed 108 
at the mRNA level in tachyzoites, with no detectable protein. TgCDPK1 protein present in 109 
Toxoplasma tachyzoites cofractionated precisely with the peak of KT5926-sensitive protein 110 
kinase activity. TgCDPK1 kinase activity was calcium-dependent but did not require calmodulin 111 
or phospholipids. TgCDPK1 was found to be inhibited effectively by KT5926 at concentrations 112 
that block parasite attachment to host cells. In vitro, TgCDPK1 phosphorylated three parasite 113 
proteins that migrated identical to the three KT5926-sensitive phosphoproteins detected in vivo. 114 
These observations suggested a central role for TgCDPK1 in regulating Toxoplasma motility and 115 
host cell invasion. 116 
Subsequent chemical genetic and conditional knockout studies have shown that 117 
TgCDPK1 is the key transducer downstream of calcium fluxes in regulating these processes.  118 
Down-regulation of TgCDPK1 expression severely impaired the secretion of micronemal 119 
proteins, including adhesins needed for gliding motility (Lourido et al., 2010).  The resulting 120 
defect in gliding motility led to a significant decrease in host cell attachment and invasion.  121 
Conditional knockout of TgCDPK1 also impaired parasite egress from host cells upon induction 122 
with a calcium ionophore, with immotile parasites remaining within vacuoles.  This coincided 123 
with a defect in PVM permeabilization upon calcium ionophore treatment, which likely resulted 124 
from impaired microneme secretion of the perforin-like TgPLP1 protein (Lourido et al., 2010). 125 
The canonical CDPK domain structure consists of an N-terminal protein kinase domain, 126 
that is highly homologous to calmodulin-dependent kinases (CaMKs), and a C-terminal CDPK 127 
activation domain (CAD) with four calcium-binding EF-hands (EF1 to EF4).  A recent 128 
biochemical and structural study of three apicomplexan CDPKs (TgCDPK1 and TgCDPK3 from 129 
T. gondii, and CpCDPK1 from Cryptosporidium parvum) has provided novel insights into how 130 
these CDPKs are activated upon Ca2+ binding by the CAD (Wernimont et al., 2010).  In in vitro 131 
assays, the kinase domain was activated by low micromolar Ca2+ concentrations.  Calcium ‘in-132 
out’ experiments suggested a partial irreversibility of this calcium-dependent activation for 133 
TgCDPK1 and TgCDPK3, while CpCDPK1 activity was reduced to basal level upon calcium 134 
removal.  Actual mapping of potential auto-phosphorylation sites may provide further insights 135 
into the reversibility of calcium-induced activation of these CDPKs. 136 
 Crystal structures have been solved for auto-inhibited (calcium-free) TgCDPK1 and 137 
TgCDPK3 and for calcium-bound TgCDPK1 and CpCDPK1 (Wernimont et al.).  The kinase 138 
domain adopts the bi-lobal structure characteristic of eukaryotic protein kinases, with a smaller 139 
N-terminal lobe (consisting mainly of β-strands) and a larger C-terminal lobe (predominantly α-140 
helical) connected together via a single stretch of polypeptide (hinge region).  A deep cleft 141 
formed between the two lobes contains the ATP binding pocket and active site (Dar, 2005).  In 142 
the calcium-free state, the CAD adopts an overall dumbbell shape (resembling calmodulin in the 143 
absence of calcium) with two EF-hands at each end of the dumbbell.  The CAD packs against the 144 
front face of the kinase domain, making contacts with both the N- and C-terminal lobes.  The N-145 
terminal helix of EF1 extends into a long helix (CH1) that spans the length of the CAD and 146 
packs anti-parallel along a second long helix (CH2).  The N-terminus of CH1 connects directly 147 
with the C-terminus of the kinase domain and packs against the kinase C-terminal lobe to block 148 
substrate binding, analogous to the pseudo-substrate segment of CAMKII (Rosenberg et al., 149 
2005) (Figure 1).  Additional hydrophobic contacts with the N- and C-terminal lobes of the 150 
kinase domain are made by EF2 and EF3, respectively.  Calcium binding to all four EF hands 151 
within the CAD causes conformational changes that expose hydrophobic surfaces and partial 152 
unwinding and bending of the CH1 and CH2 helices.  This leads to a dramatic rearrangement of 153 
the CAD into a more compact structure.  The calcium-bound CAD is also repositioned and binds 154 
to the back face of the kinase domain, which induces a widening of the active site cleft by 155 
altering the relative orientations of the two lobes of the kinase domain.  Release of the auto-156 
inhibitory interactions between the CAD and kinase domain also allows repositioning of the α-C 157 
helix and rearrangement of the P-loop and the activation loop regions into an active 158 
conformation as seen in other kinase structures. 159 
Apicomplexan CDPKs have no orthologs in humans and are most closely related to 160 
CDPKs in plants.  The essential functions of TgCDPK1 and the lack of orthologs in humans 161 
make it an ideal target for novel anti-Toxoplasma therapeutics.  In particular, TgCDPK1 is 162 
unique in having a glycine residue at the gatekeeper position, which is located at the rear of the 163 
adenine binding pocket.  ATP-analogs with bulky substituents on the purine group can be 164 
accommodated by analog-sensitive kinases with small gatekeeper residues (with glycine being 165 
the smallest), while kinases with larger gatekeeper residues cannot accommodate these 166 
molecules (Bishop et al., 2000; Blethrow et al., 2004).  Since few human kinases contain a small 167 
gatekeeper residue (no known mammalian protein kinase has glycine gatekeeper), TgCDPK1 168 
provides a promising analog-sensitive target for bumped kinase inhibitors (BKIs) that should 169 
have relatively little off-target effects on the human kinome (Manning et al., 2002). 170 
A number of BKIs have been developed for chemical genetic studies with engineered 171 
analog-sensitive kinase alleles in human cells.  BKI analogs of 4-amino-1-tert-butyl-3-172 
phenylpyrazolo[3,4-d]pyrimidine, with bulky aromatic substituents at the C3 position, inhibit 173 
TgCDPK1 at sub-micromolar concentrations (Ojo et al., 2010; Sugi et al., 2010).  Consistent 174 
with conditional TgCDPK1 knockout studies, BKIs greatly reduced host cell invasion by T. 175 
gondii and also modestly affected intracellular growth.  Parasites expressing an analog-resistant 176 
TgCDPK1, in which the gatekeeper glycine is mutated to methionine (G128M) were 177 
significantly less sensitive to BKIs and thus validated TgCDPK1 as the main BKI target in vivo.  178 
Crystal structures of calcium-free TgCDPK1 in complex with NA-PP2 and NM-PP1 confirm the 179 
structural basis for the selectivity of these BKIs for a small gatekeeper residue and will facilitate 180 
optimization of these BKIs to further improve their affinity and specificity (Ojo et al., 2010).  Of 181 
the 114 functional kinases predicted in the T. gondii genome, 12 are expected to be analog-182 
sensitive based on their gatekeeper residue (Sugi et al., 2010) .  Thus, BKIs provide a promising 183 
approach to targeting key processes in T. gondii with potentially fewer side effects on the host. 184 
That host cell invasion can be inhibited by staurosporine and involves calcium signaling has been 185 
known to also be true for malaria parasites for 2-3 decades (Scheibel et al., 1987; Ward et al., 186 
1994). More recently, a role for a CDPK (PfCDPK1) in this process has been revealed (Green et 187 
al., 2008; Kato et al., 2008), highlighting a definite level of unity in the invasion strategies across 188 
Apicomplexa.  In addition to invasion, malaria parasites exploit their repertoire of CDPKs to 189 
mediate several other developmental processes (see (Billker et al., 2009) for a comprehensive 190 
review).  Briefly, these include male gametogenesis, shown in the rodent-infecting parasite P. 191 
berghei to be dependent on PbCDPK4 (Billker et al., 2004); gliding of ookinetes, the motile form 192 
that escapes the mosquito midgut during infection of the insect vector, a process blocked in P. 193 
berghei parasites lacking PbCDPK3 (Ishino et al., 2006); and switching of parasite behavior 194 
from cell traversal to cell invasion at the early stage of liver infection by P. berghei sporozoites, 195 
which requires PbCDPK6 (Coppi et al., 2007).  There is unity across Apicomplexa not only with 196 
respect to the involvement of CDPKs in invasion, but also in the mechanism of activation of 197 
these enzymes by calcium (see above).  A recent structural study of a Plasmodium CDPK 198 
(PfCDPK3)  (Wernimont et al., 2011) revealed that the residues mediating the largest 199 
conformational change following calcium binding are the most conserved across Apicomplexa, 200 
leading the authors to propose that the mechanism described in the section above is conserved, 201 
presumably throughout the CDPK family.  Another interesting observation described in this 202 
report is that although the CAD shares similar motifs and behavior with calmodulin, there are 203 
sufficient structural differences to consider the CDPK activation domain as a distinctive member 204 
of the large EF-hand family of calcium-binding proteins.  205 
Given their key regulatory roles, malaria CDPKs also present attractive drug targets.   However, 206 
in contrast to the TgCDPKs, the presence of non-glycine residues at the gatekeeper position in 207 
malaria CDPKs will preclude the use of BKIs.   (maybe Christian can double check this?) 208 
 209 
Host modification by secreted Plasmodium and Toxoplasma protein (pseudo)kinases 210 
Unlike most other eukaryotic protein kinases, most members of the Plasmodium FIKK and 211 
Toxoplasma ROPK family have signal peptides and are predicted to be secreted into the host 212 
cell.  A recent analysis of the completed genome sequence of the three most common strains of 213 
Toxoplasma gondii by Roos and colleagues found that the Toxoplasma kinome consists of 108 214 
predicted active kinases and 51 predicted pseudokinases (Peixoto et al., 2010) (Figure 2). 215 
Compared to the human kinome, which only contains ~10% pseudokinases (Manning et al., 216 
2002), there is a significant enrichment of pseudokinases in the Toxoplasma kinome. This is 217 
mainly due to an expansion of the Toxoplasma-specific ROPK family, consisting of ~44 genes of 218 
which about half are pseudokinases.  It must be kept in mind in this context that some proteins 219 
thought to be pseudokinases on the basis of their sequence characteristics were actually shown to 220 
be competent for phosphorylation (Kannan and Taylor, 2008; Taylor and Kornev, 2010). This 221 
may be particularly relevant to sequences that are relatively distant from classical ePKs, such as 222 
the ROPKs and FIKKs (see below).  223 
  224 
Members of both the ROPK and FIKK families are characterized by a domain structure 225 
consisting of an N-terminal signal peptide, a low complexity region, and a conserved C-terminal 226 
domain that adopts a canonical protein kinase fold.  However, Toxoplasma ROP kinase domains 227 
constitute a phylogenetically-distinct group from other eukaryotic protein kinases, including 228 
other apicomplexan kinases such as the malaria FIKK family.  Proteins of the ROPK family have 229 
roles in host cell modulation and virulence, although the molecular details of how most of these 230 
proteins function are poorly understood.  While some members of the ROPK family have been 231 
shown to be active kinases (such as ROP16 (Yamamoto et al., 2009; Ong et al., 2010), and 232 
ROP18 (El Hajj et al., 2007; Khan et al., 2009b)), others appear to be pseudokinases with 233 
substitutions at key residues that abrogate catalytic activity (but see our comment above).  The 234 
inability of ROP2 to bind ATP has also been reported and may be true for other ROPK family 235 
pseudokinases (Labesse et al., 2009). 236 
Twelve sequence motifs or sub-domains are highly conserved in protein kinase domains 237 
(Hanks et al., 1988).  Most of these sub-domains are clustered within the active site cleft region 238 
and are important for ATP binding and catalysis, while others are crucial for structural stability 239 
of the protein.  The crystal structures of the ROP2 (PDB accession codes 2W1Z and 3DZO) and 240 
ROP8 (3BYV) pseudokinase domains revealed a number of structural features within their active 241 
site region that are incompatible with catalysis and ATP binding (Labesse et al., 2009; Qiu et al., 242 
2009).  Substitution of the VAIK motif with FEVH in both ROP2 and ROP8 results in loss of the 243 
critical Lysine side chain that normally coordinates the α- and ß-phosphates of ATP,  however, 244 
WNK is an example of a kinase that lacks this Lysine residue but is nevertheless active, through 245 
recruiting another residue to substitute for the missing one (Xu et al., 2000).  Replacement of the 246 
DFG motif with GFE alters the magnesium coordination geometry, while substitution of the 247 
HRD motif with HTY results in replacement of the catalytic base (Asparagine) with Tyrosine. 248 
 249 
Cellular destination of rhoptry kinases. 250 
Although it is now well established that upon invasion Toxoplasma secretes the contents of its 251 
rhoptries directly into the host cytosol, it is still unclear how these secreted proteins cross the 252 
host membrane. Patch clamp experiments have shown a short spike in conductivity at the time of 253 
invasion, which is suggestive of a break in the host membrane followed by resealing (Suss-Toby 254 
et al., 1996). The Toxoplasma protein(s) that mediate this break remain unknown. Recently, two 255 
Toxoplasma proteins with a Membrane Attack Complex/Perforin (MACPF) domain were 256 
identified, one of which (TgPLP1) is necessary for egress, which involves rupture of the 257 
parasitophorous vacuolar membrane (PVM) (Kafsack et al., 2009). TgPLP2 could be a candidate 258 
for mediating the break in the host cell plasma membrane. Once rhoptry proteins are secreted 259 
into the host cell cytosol they traffic to distinct cellular destinations based on other signals. For 260 
example the rhoptry kinase ROP16 and the rhoptry protein phosphatase 2 C (PP2C-hn) carry a 261 
nuclear localization signal (NLS), which mediates their trafficking to the host nucleus (Gilbert et 262 
al., 2007; Saeij et al., 2007). Many ROPKs traffic back to the PVM and it was recently 263 
demonstrated that an arginine-rich amphipathic helix (RAH) domain is necessary and sufficient 264 
for targeting ROPKs to the PVM (Reese and Boothroyd, 2009). Transgenic expression of the 265 
RAH domain in host cells results in punctuate staining with some overlap with the nuclear 266 
envelope. However, after Toxoplasma infection of those cells, most of the staining relocated to 267 
the PVM (Reese and Boothroyd, 2009). The fact that the RAH domain only interacts weakly 268 
with a variety of host membranes but strongly with the PVM, which is derived from the host 269 
membrane, is puzzling. It has been suggested that the RAH domain has no special affinity for a 270 
particular lipid composition but rather for negative membrane curvature as the host nuclear 271 
envelope, which is negatively curved, associated somewhat with RAH domain (Reese and 272 
Boothroyd, 2009). Indeed, it is well known that Toxoplasma secretes proteins from its dense 273 
granules that are involved in the formation of a tubulovesicular network consisting of elongated 274 
negatively curved nanotubules of 60-90 nm in diameter, which are topologically cytosolic, and 275 
connect with the vacuole-delimiting membrane. Consistent with this, parasites without the dense 276 
granule protein GRA2, which have an attenuated PVM tubular network, have attenuated 277 
recruitment of the RAH domain to the PVM (Reese and Boothroyd, 2009). Thus, an important 278 
function of dense granule proteins might be the formation of the extremely negatively curved 279 
tubular network, which subsequently functions to attract rhoptry proteins with a RAH domain 280 
from the cytosolic face of the PVM. Rhoptry proteins without a RAH domain or an NLS, such as 281 
Toxofilin stay in the host cell cytosol (Lodoen et al.). 282 
 283 
ROP16  284 
Although it has been known for some time that Toxoplasma ROPKs can be secreted into the host 285 
cytosol, their function has remained elusive. ROP2 was thought to mediate the recruitment of 286 
mitochondria to the PVM, but a recent study showed that a ROP2 knockout has no defect in 287 
mitochondrial recruitment (Pernas and Boothroyd, 2010). One of the first ROPKs for which a 288 
particular function was ascribed to was ROP16. Expression profiling of human foreskin 289 
fibroblasts (HFFs) infected with type I, II or III strain parasites demonstrated that these strains 290 
differ significantly in the modulation of host gene expression (Saeij et al., 2007). To identify the 291 
Toxoplasma genomic loci involved, expression profiles of HFFs infected with F1 progeny 292 
derived from crosses between type II and type III were determined. Quantitative trait locus 293 
(QTL) analysis, using host gene expression as the quantitative trait, determined that the genotype 294 
at a locus on Toxoplasma chromosome VIIb correlated with the strain-specific regulation of 295 
>1,000 human genes. Analyses for enrichment in functional annotation of these genes implicated 296 
the STAT signaling pathway. Indeed HFFs infected with type I or type III parasites have strong 297 
and sustained activation of STAT3 and STAT6 while the activation by type II is much weaker 298 
and only transient. A candidate gene approach identified ROP16 as the Toxoplasma gene 299 
responsible for the strain-specific activation of STAT3 and STAT6. ROP16 is secreted into the 300 
host cytosol upon infection and subsequently traffics to the host nucleus. This nuclear 301 
translocation is dependent on an NLS in ROP16 but its nuclear localization was not important for 302 
the activation of STAT3 and STAT6. Subsequently, these experiments were confirmed by other 303 
groups using a type I strain where the ROP16 gene was removed by double homologous 304 
recombination (Yamamoto et al., 2009; Ong et al., 2010). As expected, ROP16 kinase activity is 305 
necessary for its effect on STAT3 and STAT6 (Yamamoto et al., 2009; Ong et al., 2010). 306 
Initially it was predicted from sequence homology that ROP16 was a Serine/Threonine kinase 307 
and was therefore unlikely to directly phosphorylate STAT3 and STAT6. However, it has 308 
recently been shown that it can in fact directly phosphorylate these targets (Yamamoto et al., 309 
2009; Ong et al., 2010). One group showed that immunoprecipitated ROP16 can phosphorylate 310 
Tyr705 of recombinant STAT3 and subsequent co-immunoprecipitation experiments determined 311 
that the N-terminal region (amino acid 223-303) of ROP16 is required for this interaction with 312 
STAT3. By constructing chimeras between the type I and type II ROP16 proteins, the difference 313 
in STAT activation by these two alleles could be attributed to a single amino acid substitution; a 314 
conversion of Serine to Leucine at position 503 made type II ROP16 also a potent activator of 315 
STAT3. 316 
Similarly, Boothroyd and colleagues showed that ROP16 has intrinsic tyrosine kinase activity as 317 
determined by phosphoamino acid analysis of auto-phosphorylated ROP16. In vitro kinase 318 
assays with recombinant ROP16 and recombinant STAT6-GST as a substrate also showed 319 
efficient phosphorylation of Tyr641 on STAT6 by wild-type but not K404N (kinase-dead) 320 
recombinant ROP16. The pan-JAK inhibitor and the tyrosine kinase inhibitor K-252a severely 321 
impaired the kinase activity of ROP16 providing further evidence that ROP16 is a tyrosine 322 
kinase (Yamamoto et al., 2009; Ong et al., 2010). Thus, ROP16 can directly phosphorylate 323 
Tyr705 and Tyr641 from STAT3 and STAT6, respectively. This could explain why the up-324 
regulation of the suppressor of cytokine signaling (SOCS) genes, which normally down-regulate 325 
the STAT pathway (Dalpke et al., 2008), do not down-regulate the STAT3/6 activation by 326 
ROP16 (Saeij et al., 2007). SOCS proteins bind to phosphorylated tyrosine residues on Janus 327 
kinases (JAKs) and/or cytokine receptor subunits through a central SH2 domain and 328 
subsequently mediate their degradation (Dalpke et al., 2008). Because the JAKs and cytokine 329 
receptors are bypassed by the direct phosphorylation of STAT3 and STAT6 by ROP16, the 330 
inhibitory function of SOCS proteins is abrogated. By directly phosphorylating STAT3 331 
Toxoplasma could mimic the effects of IL-10, which also maintains constitutive activation of 332 
STAT3 because its receptor does not interact with the SOCS proteins (Yasukawa et al., 2003). 333 
IL-10 is a potent anti-inflammatory cytokine which can down-regulate the production of IFN-, 334 
the main mediator of resistance to Toxoplasma. The prediction would therefore be that ROP16 335 
can enhance parasite virulence by suppressing IFN- production. 336 
Indeed, ROP16 was also identified as one of the loci involved in the difference in virulence 337 
between type II and type III strains (Saeij et al., 2006). However, addition of ROP16 from type I 338 
or type III into a type II strain made it less virulent. Why type II+ROP16I/III parasites have 339 
reduced virulence is currently unknown. Although ROP16I/III can lower the level of secretion of 340 
IL-12 by macrophages infected with type II strains, which could lead to subsequent lower 341 
induction of IFN- secretion, one would predict that this would lead to an enhanced and not a 342 
reduced virulence phenotype.  343 
A potential explanation for this apparent contradiction is emerging from our recent 344 
studies showing that macrophages infected with type I or type III strains are converted into an 345 
alternatively activated or M2 macrophage (Jensen et al., 2011). These M2 macrophages are 346 
characterized by high level expression of arginase-I and several lectin receptors such as the 347 
mannose receptor and macrophage galactose specific lectin. Type II infected macrophages are 348 
converted into classically activated or M1 macrophages and secrete large amounts of 349 
proinflammatory cytokines such as IL-12p70 and IL-23. Activation of STAT6 by ROP16 is 350 
necessary to convert macrophages to the M2 phenotype, while the M1 phenotype is due to the 351 
fact that the type II strains, but not the type I and III strains, activate NFκB, a phenotype due to a 352 
new polymorphic dense granule protein GRA15 (Rosowski et al., 2011). Thus, it is possible that 353 
one of the roles of ROP16 is to limit the inflammation induced by the strong Th1 induction by 354 
Toxoplasma and the reduction of virulence of the II+ROP16I might be due to reduced immune 355 
pathology. Indeed, we have evidence that ROP16-mediated reduction of type II virulence is 356 
especially pronounced in Th1-prone mice such as C57/BL6 (Jensen et al., unpublished). 357 
Alternatively, the high induction of the arginase enzyme by ROP16 could deplete L-arginine, for 358 
which T. gondii is auxotroph, and thereby inhibit Toxoplasma growth (Butcher et al., 2011). 359 
 360 
ROP18.  361 
ROP18 was identified as a rhoptry kinase involved in virulence by two different groups (Saeij et 362 
al., 2006; Taylor et al., 2006). Sibley and colleagues were interested in the genes involved in the 363 
difference in virulence between the highly virulent type I strain (LD100=1) and the avirulent type 364 
III strains (LD50 ~ 100,000). Boothroyd and colleagues used the difference in virulence between 365 
type II (LD50 ~ 500) and type III strains as the basis for their studies. Both groups used crosses 366 
between these strains to generate F1 progeny which were subsequently injected in mice to 367 
determine their virulence phenotypes. Previously a genetic map was generated for Toxoplasma 368 
(Khan et al., 2005) and this was used to determine which Toxoplasma loci correlated with 369 
virulence. Interestingly, the only locus identified using the IxIII cross F1 progeny was ROP18 370 
and indeed a type III strain expressing type I ROP18 (III+ROP18I) was as virulent as a wild-type 371 
type I strain (Taylor et al., 2006). ROP18 kinase activity was necessary to confer virulence as the 372 
type III expressing the type I kinase dead mutant was avirulent. The difference in virulence 373 
between type II and type III strains was more complicated and implicated five different loci , one 374 
of which was ROP18.  Indeed a type III strain expressing type II ROP18 (III+ROP18II) became 375 
extremely virulent (LD50~5) (Saeij et al., 2006). The expression level of ROP18 seems to be a 376 
key determinant in the strain-specific differences in virulence. Type III strains have an extremely 377 
low level of ROP18 expression probably due to an extra 2.1 kb sequence 85 bp upstream of the 378 
ATG start codon while type I and II strains express ROP18 at a high level (Saeij et al., 2006).  379 
Although both studies demonstrated that ROP18 is secreted into the host cytosol and 380 
subsequently traffics back to the PVM, its substrate(s) remained unidentified. When ROP18 is 381 
over-expressed in host cells it also traffics to the PVM of invading parasites, showing that it has 382 
a strong affinity for the PVM (El Hajj et al., 2007; Reese and Boothroyd, 2009). Like many 383 
rhoptry proteins, ROP18 is proteolytically processed.  It is initially present as a 60 kDa protein 384 
but subsequently is processed to a 56 kDa protein. Indeed it contains the conserved S-Phe-X-E 385 
consensus motif (Phe represents bulky hydrophobic residues and X is any amino acid) for 386 
recognition by TgSUB2, a subtilisin-like serine proteinase (El Hajj et al., 2007). When 387 
comparing the ROP18 genes from multiple strains it was noted that it is one of most polymorphic 388 
proteins with evidence for strong diversifying selection. For example, the sequences of type I and 389 
type II ROP18 are very different, with almost no synonymous changes between the type I and 390 
type II alleles. Currently there is no evidence for a different function of the different ROP18 391 
alleles, because quite diverse ROP18 alleles from several strains all confer virulence to type III 392 
parasites when expressed in this avirulent strain(Khan et al., 2009b). It is also unknown if over-393 
expression of the type III ROP18 itself would also confer virulence. Comparison of the ROP18 394 
genomic region between Toxoplasma and Neospora caninum, a close relative of Toxoplasma 395 
gondii, demonstrated that Neospora also has the extra region in the promoter of its ROP18. Thus, 396 
the most parsimonious explanation is that the ancestral ROP18 gene contained the extra 397 
sequence in its promoter resulting in low level expression and subsequently this region was 398 
deleted to give rise to the more recently derived type I and type II ROP18 alleles (Khan et al., 399 
2009b). It was also hypothesized that strains carrying the type I ROP18 allele might be more 400 
successful because more strains have a ROP18 allele similar to the type I strain; however this 401 
could also be due to other strains being more similar to type I strains compared to type II strains . 402 
 403 
Proposed regulatory mechanism of ROP18.  404 
Protein kinases display a diverse array of regulatory mechanisms that exploit multiple ways of 405 
impeding or distorting the binding of ATP, magnesium or protein substrates to prevent catalysis.  406 
This often involves a distortion of the inter-lobe orientation, conformational change of the 407 
activation loop to block ATP and/or substrate binding, or occlusion of the active site.  Activation 408 
of the kinase domain often involves phosphorylation (particularly of the activation loop), but 409 
may also involve other mechanisms such as binding or dissociation of regulatory domains or 410 
subunits (Huse and Kuriyan, 2002; Dar, 2005). 411 
The ROP2 and ROP8 kinase domain crystal structures revealed a unique N-terminal subdomain 412 
that is conserved in other ROPK family kinase domains and contains features that preclude ATP 413 
binding in two of the ROPK pseudokinase structures determined.  This ~40 residue N-terminal 414 
extension consists of an α-helical segment (packed against the C-terminal lobe) connected via a 415 
short linker region to an α-helix and ß-strand packed against the N-terminal lobe.  In both 3DZO 416 
and 3BYV, an arginine side chain from the N-terminal subdomain linker region (Arg 219 in 417 
3DZO and Arg 228 in 3BYV) forms a salt bridge interaction with the side chain of Glu 284 in 418 
3DZO and Glu 293 in 3BYV.  The glutamate and arginine side chains occupy the expected 419 
position of the ATP adenine group.  Based on a homology model of the ROP18 kinase domain 420 
(with the ROP8 crystal structure as a template), a novel kinase regulatory mechanism was 421 
proposed for ROP18, in which the N-terminal subdomain was predicted to impede ATP-binding 422 
(as observed in 3DZO and 3BYV).  Furthermore, phosphorylation at sites within and near the 423 
ROP18 N-terminal subdomain was proposed to regulate this auto-inhibition (Qiu et al., 2009). 424 
Similar to other active protein kinases and in contrast to the ROP2 and ROP8 structures, 425 
the modeled active site of ROP18 was free of bulky side chains that would preclude ATP 426 
binding, with the exception of Gln 214 and Gln 216.  The side chains of both residues were 427 
predicted to protrude into the ATP binding pocket from the N-terminal subdomain linker region 428 
(analogous to Arg 219 in 3DZO and Arg 228 in 3BYV).  Consistent with the homology model, 429 
mutation of Gln 214 and Gln 216 to Ala resulted in a three to four fold increase in in vitro auto-430 
phosphorylation and phosphorylation of myelin basic protein by recombinant ROP18 kinase 431 
domain.  Activation was then suggested to involve a displacement or conformational change of 432 
the N-terminal subdomain to move the side chains of Gln 214 and Gln 216 out of the ATP 433 
binding pocket.  ROP18 kinase domain expressed in Escherichia coli was auto-phosphorylated 434 
on Ser 221 and Thr 229 (second helix of the N-terminal subdomain), and on Thr 249 and Thr 435 
251 (in contact with the N-terminal subdomain β-strand).  Mutation of these Ser and Thr residues 436 
to Ala, reduced in vitro kinase activity by up to 90% (Qiu et al., 2009).  It was therefore 437 
proposed that phosphorylation of one or more of these Ser/Thr residues activated ROP18 by 438 
altering the interaction of the N-terminal subdomain with the N-terminal lobe to shift the linker 439 
region containing Gln 214 and Gln 216 away from the ATP binding pocket.  However, several 440 
aspects of this proposed auto-inhibitory mechanism require further investigation.  Comparison of 441 
the available crystal structures, suggests that loss of the salt bridge interaction between the 442 
glutamate side chain within the adenine binding pocket (Glu 284 in 3DZO and Glu 293 in 443 
3BYV) and the arginine side chain on the N-terminal subdomain linker (Arg 219 in 3DZO and 444 
Arg 228 in 3BYV) displaces the N-terminal subdomain linker away from the active site as can be 445 
seen in 2W1Z.  Since this salt bridge interaction is also not conserved in ROP18, it is unclear if 446 
the N-terminal subdomain linker in ROP18 adopts the auto-inhibitory conformation as seen in 447 
3DZO and 3BYV.  The auto-phosphorylation sites within the ROP18 N-terminal subdomain 448 
were mapped using recombinant protein, and whether these sites are phosphorylated in vivo and 449 
even the extent to which these sites were auto-phosphorylated in vitro were not reported.  Kinase 450 
assays of recombinant ROP18 following phosphatase treatment were not presented, but may help 451 
to verify the importance of auto-phosphorylation in activating ROP18.  Given the importance of 452 
the N-terminal subdomain to the proper folding of ROP18, it remains formally possible that the 453 
N-terminal Ser/Thr to Ala mutants decreased kinase activity by destabilizing ROP18 structure.  454 
Conversely, the effect of phospho-mimicking mutations of these N-terminal Ser/Thr residues to 455 
Asp or Glu on kinase activity were also not reported, but may provide a useful alternative means 456 
to test the importance of these phosphorylation sites in activating ROP18. 457 
 458 
What are the substrates for ROP18? 459 
The effect of ROP18I on type III virulence could be due to its effect on parasite growth; vacuoles 460 
with type III+ROP18I have on average twice as many parasites at 40hrs post-infection when 461 
compared to vacuoles with wild-type type III strain parasites (El Hajj et al., 2007). This effect of 462 
ROP18 on parasite growth seems to be vacuole autonomous as only parasites in vacuoles of type 463 
III+ROP18I have a shorter replication time even if they are next to a vacuole with a wild-type 464 
type III strain. Because this result was obtained in HFFs, possible host targets for ROP18 should 465 
be present in non-stimulated HFFs and are most likely present on the vacuole itself. Besides 466 
parasite proteins such as rhoptry proteins and dense granule proteins, several host proteins have 467 
also been described to relocalise to the PVM.  468 
The most interesting potential substrates, at least in murine cells, would be the immunity-related 469 
GTPases (IRGs). These small GTPases are related to dynamins but are highly induced upon IFN-470 
 stimulation of cells and subsequently traffic to the PVM where they mediate dynamin-like 471 
vesiculation and subsequent rupture of the PVM and eventually the destruction of the parasite 472 
(Martens et al., 2005; Ling et al., 2006; Melzer et al., 2008). The accumulation of IRGs on the 473 
parasite PVM is also a strain-specific phenotype; Type I vacuoles seem to resist high 474 
accumulation of these IRGs and indeed type I vacuoles are resistant to destruction, while type II 475 
and III vacuoles accumulate high levels of the IRGs and are effectively destroyed by IFN- 476 
(Zhao et al., 2009a; Zhao et al., 2009b). To investigate if ROP18 had a role in this strain specific 477 
difference, the accumulation of IRGs on vacuoles of type III infected cells was compared to 478 
vacuoles of type III+ROP18I but no difference in accumulation of ROP18 was observed (Zhao et 479 
al., 2009a). Similarly, transfection of ROP18I or ROP18II into IFN- -induced L929 fibroblasts 480 
had no effect on the accumulation of IRGs on type II vacuoles (Khaminets et al., 2010).  481 
In contrast to the above mentioned studies it was recently reported that ROP18I can bind to and 482 
directly phosphorylate Irga6, Irgb6 and Irgb10 (Fentress et al., 2011; Steinfeldt et al., 2011), 483 
thereby preventing their accumulation on the PVM. For Irga6 it was demonstrated that ROP18 484 
can phosphorylate two threonine residues in the switch I loop (T102 and T108) (Steinfeldt et al., 485 
2011), while Irgb6 was mainly phosphorylated on a single threonine residue in its switch I loop 486 
(Fentress et al., 2011). Because these threonine residues are at the catalytic interface that is 487 
essential for GTP-dependent active dimer formation, it is likely that their phosphorylation 488 
inactivates the protein. Indeed, phospho-mimetic mutants of Irga6 were inefficiently loaded onto 489 
the PVM and could inhibit loading of wild-type Irga6 (Steinfeldt et al., 2011). Antibodies 490 
specific for pT102 and pT108 demonstrated that type I vacuoles indeed contained significant 491 
amounts of pT102 and pT108. Type II vacuoles did not contain any pT102 but did contain 492 
pT108 although significantly less compared to type I strains. If the phosphorylation of T108 is 493 
mediated by type II ROP18 remains to be determined. The phosphorylation of Irgb6 is of 494 
particular interest as this is one of the first IRGs recruited to the vacuole and it has been proposed 495 
to mediate the subsequent recruitment of other IRGs. Indeed knockdown of Irgb6 resulted in 496 
significantly less killing of Toxoplasma by IFN- stimulated macrophages. 497 
It was speculated that the difference between the studies reporting an effect of ROP18 and 498 
studies reporting no effect (all studies were performed by the same two groups) was the IFN- 499 
concentration; only at a low (<1 Unit/ml) IFN- concentration was an effect of ROP18I 500 
expressed in type III on Irga6 loading on the vacuole detectable. This probably indicates that 501 
other polymorphic parasite proteins play a role in resistance to the IRG system, because type I 502 
strains can inhibit IRG loading even after stimulation of 200 Units/ml IFN-. The specific cell 503 
type used might also be important. Sibley and colleagues demonstrated that prevention of IRG 504 
accumulation on vacuoles of parasites expressing ROP18I prevents the killing of Toxoplasma by 505 
GR1+ inflammatory monocytes or IFN- stimulated macrophages. 506 
That ROP18 is not the only factor responsible for reduced IRG loading might also explain why 507 
type III+ROP18II are as virulent as type III+ROP18I, while the PVM of type II strain itself is 508 
efficiently coated by the IRGs. Possibly the type II strain lacks another polymorphic Toxoplasma 509 
protein, present in both type I and type III, that is necessary for ROP18 activity in vivo or it could 510 
contain a protein that somehow blocks ROP18 activity. Furthermore, it is unlikely that the IRGs 511 
are the only substrates for ROP18 because these IRGs are not expressed in human cells or non-512 
stimulated cells and the effect of ROP18 on parasite growth was reported in un-stimulated HFFs. 513 
Based on the ability of bacterially-expressed and refolded ROP18 kinase to phosphorylate 70 kD 514 
and 68 kD proteins in heat-inactivated parasite lysates, it has been suggested that ROP18 can 515 
also phosphorylate parasite-derived proteins (El Hajj et al., 2007). It is possible that these 516 
proteins are in fact ROP2, ROP8 or ROP18 itself as bacterially-expressed versions of those 517 
proteins were also shown to be phosphorylated by ROP18. However, whether these proteins are 518 
bona fide substrates in an infected cell remains unknown.  519 
 A number of unbiased strategies may be pursued for the identification of substrates or 520 
interactors of ROPK family active kinases and pseudokinases (Sopko and Andrews, 2008).  521 
Engineering a kinase of interest (by mutation of its gatekeeper residue to Gly or Ala, see below) 522 
to accept ATPγS analogues containing bulky substituents, allows chemical tagging of its direct 523 
substrates.  Subsequent alkylation of the thiophosphate groups allows isolation of the tagged 524 
substrates by a thiophosphate ester-specific antibody for identification by mass spectrometry 525 
(Allen et al., 2007).  Due to the cell impermeability of ATP analogues, substrates must be 526 
thiophosphorylated in lysates, where the relative spatial organization of kinases and their 527 
substrates can be lost, potentially leading to false positives (Blethrow et al., 2004).  Additionally, 528 
not all kinases are compatible with gatekeeper mutations required for analogue-sensitivity and/or 529 
with thiophosphorylation.  A potential problem for the Toxoplasma kinome discussed earlier in 530 
the present review is the presence of a number of endogenous analog-sensitive kinases, such as 531 
TgCDPK1, that inherently have small gatekeeper residues, which may further complicate this 532 
approach (Sugi et al., 2010).  An alternative method of kinase substrate identification utilizes 533 
mass spectrometry to detect changes in the abundance of phospho-sites due to the knockout of a 534 
kinase or treatment with a specific small molecule inhibitor, if available (Sopko and Andrews, 535 
2008).  Due to the effects on possible downstream kinases, substrates identified by this approach 536 
may not be direct, although it may be possible to filter out such indirect “false positives” with 537 
knowledge of the phosphorylation motif of the kinase of interest.  The use of a positional-538 
scanning peptide array (Hutti et al., 2004) to define the substrate preference of ROP18 was 539 
recently published (Fentress et al., 2011).  Other approaches to identify kinase substrates that are 540 
also amenable to identifying interactors of pseudokinases include yeast 2-hybrid and co-541 
purification of ligands / substrates with a tagged kinase or pseudokinase from cell lysates (Sopko 542 
and Andrews, 2008).  The sensitivity of yeast 2-hybrid can facilitate the detection of transient 543 
kinase-substrate interactions, which may be stabilized by the use of a catalytically-inactive 544 
kinase bait.  545 
 546 
ROP5, a pseudokinase essential for Toxoplasma virulence. 547 
The analysis of virulence of the F1 progeny from IIxIII crosses identified a locus on Toxoplasma 548 
chromosome XII as having the largest contribution to the strain-specific differences in virulence. 549 
Interestingly, the avirulent type III strain contributed to the enhanced virulence while the more 550 
virulent type II strain contained the avirulent locus (Saeij et al., 2006). 551 
It was recently demonstrated that the pseudokinase ROP5 is responsible for this difference in 552 
virulence (Reese et al., 2011). Initially a completely avirulent F1 progeny (S22, LD50> 1x106 553 
parasites) was complemented with a type I cosmid containing ROP5 and a 4 log increase in 554 
virulence was noted. However, because the cosmid contained two other genes, a refined analysis 555 
was needed. Therefore the ROP5 locus was deleted in a type I strain, and surprisingly this strain 556 
was completely avirulent (LD50 > 1x106) (Reese et al., 2011). The ROP5 locus is quite 557 
complicated and it seems that type II strains contain 10 copies of ROP5, type I: 4 copies and type 558 
III: 6 copies. These copies consist of at least three different alleles for each strain, with the type I 559 
and III alleles being the most similar. Complementation of the type I knockout with one allele 560 
increased virulence, while only complementation with two or more alleles converted the 561 
virulence to wild-type virulence. The crystal structure of the ROP5BI kinase domain showed a 562 
canonical protein kinase domain fold and is highly similar to the crystal structures of the ROP2 563 
and ROP8 pseudokinase domains (Reese & Boothroyd, 2011). However ROP5 was predicted to 564 
be inactive due to the substitution of the Asp residue within the HRD motif (catalytic base) with 565 
a basic residue (Lys or His depending on the ROP5 allele). Consistent with this, no detectable 566 
kinase activity was reported for recombinant ROP5 protein in vitro. The ROP5 pseudoactive site 567 
is able to bind ATP, and the crystal structure revealed a distorted ATP binding mode, due to an 568 
unusual positioning of magnesium coordination sites.  ROP5 is also not predicted to be 569 
processed because it lacks the subtilisin cleavage motif. Sibley and colleagues recently made a 570 
cross between a type I and a type II strain and reported that a single QTL, containing the ROP5 571 
gene cluster, controls virulence difference between these strains (Behnke et al., 2011). Indeed, 572 
through similar studies as described above they determined that ROP5 determines the differences 573 
in virulence between the type I and type II strains. The fact that ROP18 did not determine 574 
virulence differences between type I and type II indicates that indeed type I and type II ROP18 575 
seem to be functionally equivalent. Although only a single QTL was identified this does not 576 
mean that other genes are not involved in determining virulence differences between the type I 577 
and type II strains. For example, some of the F1 progeny from the IxII cross contain both the 578 
virulent ROP5 and ROP18 alleles but are not 100% lethal indicating that other genes must be 579 
involved (Behnke et al., 2011).  580 
The mechanism underlying ROP5-mediated virulence is currently unknown. Restoration of the 581 
catalytic base within the HRD motif by substitution of the basic residue in the ROP5AIII allele 582 
with Asp resulted in significantly reduced virulence in mice. However the equivalent substitution 583 
in the ROP5BI allele did not restore in vitro catalytic activity in recombinant protein, and the 584 
basis for the reduced virulence conferred by the ROP5AIII R389D mutant is unclear (Reese & 585 
Boothroyd, 2011). To compare the contribution of ROP5 to virulence with that of ROP18, a 586 
ROP18 knockout strain was also created. Surprisingly, the type I ROP18 knockout strain was as 587 
virulent as the wild-type strain and only a slight delay till death was noted. This seems to 588 
contradict the important role of ROP18 in virulence that was previously demonstrated by 589 
complementation of the avirulent type III strain, and it also raises the question of the importance 590 
of evasion of the IRG system. Indeed, Sibley and colleagues also found that although the 591 
RHROP18 KO had a delayed time-till-death phenotype, it was still 100% lethal. It should be 592 
noted, however, that ROP18 was knocked out in the RH type I strain while the QTL analysis of 593 
virulence was performed using the GT1 type I strain. It was recently noted that these strains 594 
behave quite differently; RH has a faster duplication time, it survives much better extracellularly 595 
and a significant number of parasite genes is differentially expressed compared to GT1 (Khan et 596 
al., 2009a). It would therefore be interesting to remove ROP18 in the GT1 background and 597 
investigate its virulence phenotype. 598 
Although the ROPK family pseudokinases are not expected to directly phosphorylate target 599 
proteins, they may play scaffolding roles in allosteric regulation of active kinases or mediating 600 
kinase–substrate interactions (Zeqiraj and van Aalten, 2010).  The crystal structure of the LKB1-601 
STRADα-MO25α ternary complex revealed the structural basis of how the STRADα 602 
pseudokinase helps to maintain the LKB1 kinase in an active conformation.  LKB1 interacts as a 603 
pseudosubstrate with regions of STRADα that correspond to the substrate binding site in active 604 
protein kinases (Zeqiraj et al., 2009).  Consistent with this theme, the substrate binding loops of 605 
ROP2 and ROP8 are well ordered and structurally conserved between the 3DZO and 3BYV 606 
crystal structures.  However, differences in the surface electrostatic potentials in the ROP2 607 
(partly neutral and negative) and ROP8 (highly positively charged) pseudosubstrate binding 608 
regions suggest different ligand specificities (Qiu et al., 2009).  609 
 610 
ROP38. 611 
After analysing the complete Toxoplasma kinome, Roos and colleagues further characterized the  612 
ROP38 gene for the following reasons: it was predicted to be an active kinase, it was 613 
differentially expressed between strains (up >64 fold in type III; >8 fold in type II as compared 614 
to type I), it was induced upon differentiation from tachyzoites to bradyzoites, it was triplicated 615 
in both Toxoplasma and Neospora, and there was evidence for convergent evolution of 616 
Toxoplasma ROP38 and its Neospora homologue (Peixoto et al., 2010). Because its expression is 617 
very low in type I strains they decided to study its function by over-expressing HA-tagged type I 618 
ROP38 using a tubulin promoter in a type I strain. HA-tag staining of infected cells confirmed 619 
colocalization of ROP38 with ROP2 indicating that it is indeed a rhoptry protein. ROP38 was 620 
also observed on the PVM, which contrasts with a previously published report that it does not 621 
traffic to the PVM (ROP38 corresponds to ROP2L5 in that paper) (Reese and Boothroyd, 2009). 622 
It is possible that the over-expression of ROP38 resulted in mislocalisation, anddefinitive 623 
localization will depend on staining with an antibody recognizing endogenous ROP38. To 624 
determine if ROP38, like ROP16, modulates host cell gene expression, host microarrays were 625 
performed after infection with type I+ROP38I or wild-type type I. Interestingly, expression of the 626 
ROP38 transgene was able to suppress a large proportion of genes that are normally regulated by 627 
type I infection. Preliminary experiments suggested that ROP38 might modulate the MAPK 628 
pathway, as the kinetics of ERK phosphorylation was different in type I-infected vs type 629 
I+ROP18I infected cells. However, this difference in the modulation of host gene expression 630 
seemed to have no consequences for virulence in mice as type I over-expressing ROP38 was as 631 
virulent as wild-type type I. 632 
 633 
The Plasmodium kinome. 634 
 The P. falciparum kinome has been reported to comprise 85 or 99 enzymes, depending on 635 
the stringency applied for inclusion of borderline sequences (Ward et al., 2004;Anamika and 636 
Krupa, 2005).  Both studies concur to present a picture of a the Plasmodium kinome as being 637 
characterized by significant divergences from the yeast or metazoan kinomes (reviewed in 638 
Doerig and Meijer, 2007; Doerig et al., 2010). 639 
Most established eukaryotic PK groups have members in Plasmodium, although TyrK 640 
(tyrosine protein kinases) and STEs (a group of PKs involved in mitogen-activated protein 641 
kinase [MAPK] pathways) are not represented.  The Plasmodium kinome comprises two 642 
atypical MAP kinases, but the absence of typical MAPKKs suggests that activity of these two 643 
enzymes is regulated in a way that differs from that found in classical eukaryotic MAPKs 644 
pathways.  These atypical MAPKs are but an example of a number of plasmodial PKs that 645 
can be classified as belonging to established ePK families, but cannot be assigned precise 646 
orthology with specific mammalian enzymes (for examples, see Abdi et al., 2010;Agarwal et 647 
al., 2011; Dorin et al., 2001;Dorin et al., 1999; Reininger et al., 2005; Fennell et al., 2009; 648 
Reininger et al., 2009;Halbert et al., 2010;Reininger et al., 2011)).  The Plasmodium kinome 649 
also includes many enzymes that do not cluster with any of the PK groups and families 650 
established from the yeast and mammalian kinomes, such as the FIKK kinases, which are 651 
specific to apicomplexan parasites (Schneider and Mercereau-Puijalon, 2005), and the 652 
CDPKs (see above) (.   Interestingly, individual PKs displaying sequence features that are 653 
characteristic of distinct ePK groups are found in the P. falciparum kinome, illustrating its 654 
evolutionary divergence from other kinomes (Dorin et al., 2001;Bracchi-Ricard et al., 655 
2000;Dorin et al., 2005).  A notable example of such “composite kinases” is Pfnek-1, which 656 
has a clear relatedness to the NIMA family despite the presence of a MAPKK-like putative 657 
activation site (Dorin et al., 2001). 658 
A systematic kinome-wide knock-out approach in P. berghei identified several PKs as essential 659 
for development in the mosquito (genetic manipulations are significantly more straightforward in 660 
the rodent malaria P. berghei than in P. falciparum, because (i) gene replacement by double 661 
cross-over occurs at a much higher rate in the former than in the latter, and (ii) the selection of 662 
transformed parasites occurs in the mouse and is much faster than the in vitro cultivation of P. 663 
falciparum (Carvalho and MÃ©nard, 2004)).  A similar study has recently addressed essentiality 664 
of 62 of the 65 P. falciparum ePKs (this study excluded the FIKKs, see above).  The inability to 665 
knock-out a given locus, together with the ability to modify the allele in a way that does not 666 
cause loss-of-function of the gene product (e.g. tagging the C-terminal end with HA epitopes or 667 
with GFP), is interpreted as strongly indicative of an essential role of that locus during 668 
schizogony.  36 kinases were thus identified as playing a crucial role is erythrocytic schizogony, 669 
while 26 are most likely dispensable for this part of the life cycle (with cloned parasite lines 670 
having thus far been obtained for 12 of these) (Solyakov et al., Nature Communications, in 671 
revision). 672 
 673 
Plasmodium exported kinases.  674 
Plasmodium expresses a set of unique kinases, the FIKKs (Ward et al., 2004), 16 of which are 675 
predicted to be exported into the RBC because of the presence of a PEXEL motif in their N-676 
terminal region (Schneider and Mercereau-Puijalon, 2005).  The roles played by FIKK in the 677 
RBC are much less well understood than those of some of the ROPKs in Toxoplasma-infected 678 
cells discussed above.  We know that a significant subset of FIKKs are indeed exported into the 679 
RBC shortly following parasite invasion (Nunes et al., 2007; Nunes et al., 2010)and that at least 680 
one member of the family remains within the parasite, despite possessing a recognizable 681 
PEXEL(Nunes et al., 2007).  Most fikk genes are located in the sub-telomeric regions of 10 of the 682 
14 chromosomes in P. falciparum, in the vicinity of the var genes that mediate cytoadherence 683 
and antigenic variation.  The var genes are under allelic exclusion control, with a single PfEMP1 684 
(var-encoded) protein expressed at a time;  this appears not to be the case for the fikk genes. 685 
Interestingly, however, expression of a subset of fikk genes was modulated in parasites 686 
undergoing a switch in their cytoadherence phenotype (Nunes et al., 2007).  Knock-out studies 687 
implicated 2 FIKKs in the remodeling of the RBC membrane skeleton, as distinct 688 
phosphorylation profiles in ghost preparations of parasite-infected RBCs were detected for each 689 
of the knock-out parasite clones (Nunes et al., 2010).  In addition to FIKKs, a number of 690 
Plasmodium kinases have been reported to be exported into the RBC (Kun et al., 1997; 691 
Droucheau et al., 2004; Vaid et al., 2010) or even secreted to the extracellular milieu (Singh et 692 
al., 2009). Recent data demonstrate that infection with malaria parasites causes a dramatic 693 
activation of a signaling pathway involving host RBC PAK and MEK kinases, and that 694 
pharmacological interference with these enzymes using highly selective allosteric inhibitors is 695 
lethal for the parasite (Sicard et al., 2011).  The parasite is also known to interfere with host cell 696 
signaling in the liver stages (reviewed in (Luder et al., 2009)), resulting in down-regulation of the 697 
NFκB pathway (Singh et al., 2007) and in prevention of apoptosis of host hepatocytes (van de 698 
Sand et al., 2005). 699 
 700 
Thus, it appears that in both Toxoplasma and Plasmodium, two apicomplexan parasites 701 
that are phylogenetically widely divergent from each other (Kuo et al., 2008), calcium-regulated 702 
protein phosphorylation mediated by CDPKs plays central roles in regulating their entry into and 703 
egress from the host and other developmental processes, and that both parasites export proteins 704 
into their host cell to tailor it to their own needs.  The secretion of virulence factors into the host 705 
is a strategy widely used not only by Apicomplexa (a striking further apicomplexan-based 706 
example of this concept is the reversible transformation of leucocytes by Theileria (reviewed in 707 
(Shiels et al., 2006)), but also by many if not all intracellular parasites (reviewed in (Munter et 708 
al., 2006)).  This not only provides a fascinating fundamental glimpse into unique signaling 709 
mechanisms operating within parasites and between parasites and their hosts, but also suggests 710 
opportunities for novel therapeutic intervention. 711 
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FIGURE LEGENDS 1008 
Figure 1: Comparative schematic of activation of CDPKs and CaMKs. The green lines represent 1009 
the auto-inhibitory region. CaM = Calmodulin, CAD = CDPK-activating domain. See text for 1010 
details. [Reproduced from “A parasite calcium switch and Achilles’ heel revealed. (Doerig and 1011 
Billker, 2010)]. 1012 
Figure 2: The Toxoplasma kinome.  1013 
Classification of 108 active kinases predicted from the T. gondii genome. Black, human and 1014 
yeast; blue, P. falciparum; red, T. gondii. Colored arcs 1015 
highlight major kinase groups: AGC, CMGC, CAMK, TKL, CK1, and STE. Red lettering, 1016 
apicomplexan-specific groups ROPK (pink) and FIKK. Red circles, kinases with predicted 1017 
secretory signal sequence or signal anchor (open, newly recognized); black dots, bootstrap 1018 
support > 50%. [Reproduced from (Peixoto et al., 2010)] 1019 
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